Stay updated with breaking news from Solid Tumor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Trillium Therapeutics is up against some stiff competition to become a leader in the new class of drugs called CD47, which turn off the “don’t eat me” signal transmitted by cancer cells, but CEO Jan Skvarka believes his biotech’s data will stand for themselves.
New Stem Cell Therapy Stops Spread of Breast Cancer by Hannah Joy on March 8, 2021 at 6:33 PM A biology-driven, Stem-Cell therapy fights against solid tumors; especially stops brain cancer that metastasizes to the brain, reveals a new study. Approximately 15-to-30 percent of patients with metastatic breast cancer have brain metastasis (BM), with basal-like breast cancer (BLBC) metastasizing to the brain most frequently. The prognosis for BLBC-BM patients is poor, as the blood-brain barrier prevents most therapeutics from reaching the brain. ‘Engineered 'off the shelf' s...
Scientific breakthroughs, approvals: Latest CAR T-cell therapy related developments From new research offering promise for children's cancer to FDA registrations, we track the progress made in the past few weeks in terms of advancing CAR T-cell therapy in a number of markets. Novartis on Friday [February 12] reported that it had received approval from Australian regulatory agency, Therapeutic Goods Administration (TGA), for Cell Therapies to manufacture and supply its CAR-T therapies commercially for eligible patients in that market. The Cell Therapies manufacturin...
WCCB Charlotte's CW February 10, 2021 CHARLOTTE, N.C. (News Release) — Isabella Santos Foundation (ISF) a Charlotte childhood cancer charity was created in honor of Isabella Santos who lost her fight to neuroblastoma, a rare pediatric cancer, at just seven years old. On March 9th, Isabella would have turned 16-years-old. While she only lived seven years, Charlotte, the nation, and the world feel her astounding impact through the creation of the ISF Rare & Solid Tumor Program at Atrium Health Levine Children’s. This program is quickly becoming a national and international destination for h...
Share this article Share this article ResearchAndMarkets.com's offering. The fast pace of cancer prevalence and mortality rate across the globe has led to an increasing concern as well as recognition that the specific disease requires attention by the researchers. In the past few years, the type of research activities that have been conducted for cancer disease has moved several laboratory findings to the commercial world. In one of the scenarios, development of cancer biological toxins is a form of novel technology facility resulted from the translational research conducted at different res...